Inactivated vaccine against feline calicivirosis
AssigneeMerial Limited
InventorsHerve Poulet, Sylvian Gabriel Goutebroze
Life of this patent
Estimating the term…
Abstract
Immunogenic preparations and vaccines, in particular which are inactivated, effective against feline calicivirosis, based on an FCV virus strain 431 as deposited at the CNCM under the accession number CNCM I-2166, or one of its equivalents, in a veterinarily acceptable vehicle or excipient, preferably combined with FCV virus obtained from another FCV strain, in particular strain G1 as deposited at the CNCM under the accession number CNCM I-2167.
Claims15
An immunogenic composition comprising an isolated feline calicivirus (FCV) that binds to monoclonal antibody 44, secreted by the hybridoma deposited at the CNCM under accession number I-2282, a veterinarily acceptable vehicle or excipient, and at least one valency against at least one other feline pathogen.
An immunogenic composition comprising an isolated feline calicivirus (FCV) strain 431 deposited at the CNCM under accession number I-2166, a veterinarily acceptable vehicle or excipient, and at least one valency against at least one other feline pathogen.
Dependencies are inferred from the claim text.